Gainers
-
Biocept, Inc. (NASDAQ: BIOC) shares
rose 73.6 percent to $1.19 after the company entered a software license and laboratory data supply agreement with Prognos.
-
Marin Software Incorporated (NASDAQ: MRIN) shares climbed 37.8 percent to $3.94 after the company announced it has
entered a revenue sharing agreement with Google. The company also raised Q4 guidance.
-
Navistar International Corporation (NYSE: NAV) rose 17.8 percent to $28.08 after the company reported better-than-expected
results for its fourth quarter.
-
ReShape Lifesciences Inc. (NASDAQ: RSLS) gained 15.5 percent to $0.4750 after the company acquired Apollo
Endosurgery's lap-band system.
-
Kodiak Sciences Inc. (NASDAQ: KOD)
shares climbed 15.3 percent to $7.68.
-
CollPlant Holdings Ltd. (NASDAQ: CLGN)
shares gained 14.2 percent to $4.98.
-
Materialise NV (NASDAQ: MTLS) shares
climbed 12.9 percent to $17.82.
-
Limbach Holdings, Inc. (NASDAQ: LMB)
gained 12.1 percent to $3.99.
-
The Meet Group, Inc. (NASDAQ: MEET)
rose 11.3 percent to $3.7511. The Meet Group reported that annualized video revenue run-rate rose to $62 million in November,
up from $55 million in October.
-
Tyme Technologies, Inc. (NASDAQ: TYME)
gained 10.5 percent to $3.58.
-
NRC Group Holdings Corp. (NASDAQ: NRCG) climbed 9.4 percent to $9.31.
-
SMART Global Holdings, Inc. (NASDAQ: SGH) rose 9.2 percent to $30.65. SMART Global will replace XO Group in the
S&P SmallCap 600 on Monday, December 24.
-
Tilray, Inc. (NASDAQ: TLRY) climbed
8.1 percent to $71.20 after the company announced a partnership with German pharmaceutical company Sandoz to distribute
non-smokable medical cannabis products.
-
Boot Barn Holdings, Inc. (NYSE: BOOT)
climbed 7.6 percent to $17.12.
-
Scientific Games Corporation (NASDAQ: SGMS) shares rose 7.5 percent to $17.05.
-
Cellect Biotechnology Ltd. (NASDAQ: APOP) shares gained 6.8 percent to $2.67.
-
HealthEquity, Inc. (NASDAQ: HQY) gained
6.6 percent to $63.59. Cantor Fitzgerald upgraded Healthequity from Neutral to Overweight.
-
HEICO Corporation (NYSE: HEI) climbed 5.9
percent to $82.44 after the company beat Q4 EPS and sales estimates.
-
FibroGen, Inc. (NASDAQ: FGEN) rose 5.6
percent to $41.17 after the company said its China unit has received marketing authorization from the National Medical Products
Administration for Roxadustat, a hypoxia-inducible factor propyl hydroxylase inhibitor for treating patients with anemia caused
by chronic kidney disease, who are dialysis dependent.
-
NCR Corporation (NYSE: NCR) shares gained
5.3 percent to $23.90. RBC Capital upgraded NCR from Outperform to Top Pick.
-
Puma Biotechnology, Inc. (NASDAQ: PBYI) rose 5 percent to $22.48 after the company reported favorable results
from its Phase III NALA trial of Neratinib in breast cancer patients.
Check out these big penny stock gainers and
losers
Losers
-
Nemaura Medical Inc. (NASDAQ: NMRD)
shares tumbled 39.2 percent to $0.8450 after the company priced its $2.5 million share common stock offering at $1.02 per
share.
-
Champions Oncology, Inc. (NASDAQ: CSBR) shares declined 18.4 percent to $7.79. Champions Oncology reported Q2
revenues of $6.7 million, up 28.6 percent year-over-year, and non-GAAP EPS of 3 cents compared to break-even results a year
ago.
-
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) dipped 17.4 percent to $2.33.
-
OptimizeRx Corporation (NASDAQ: OPRX)
dipped 16.8 percent to $9.65 after the company priced its offering of approximately 2.1 million shares at $10 per share.
-
Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) shares fell 16.3 percent to $7.54.
-
Cancer Genetics, Inc. (NASDAQ: CGIX)
dipped 15.9 percent to $0.2800 on continued weakness after the company on Monday announced it has terminated its proposed
merger with NovellusDx.
-
Motus GI Holdings, Inc. (NASDAQ: MOTS)
shares dropped 15.8 percent to $2.6942 after reporting a proposed 5 million share follow-on offering of common stock.
-
Rent-A-Center, Inc. (NASDAQ: RCII)
fell 15.6 percent to $12.19 after terminating its merger agreement with Vintage Capital.
-
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares dropped 14.8 percent to $2.0450 after the company reported
positive interim Phase 2 trials of its first-gen oral factor D inhibitor ACH-4471, as well as pharmacokinetics and potency data
for its next-gen factor D inhibitors ACH-5228 and ACH-5548.
-
Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 14.3 percent to $3.4700 after climbing 15.71 percent on Monday.
-
NF Energy Saving Corporation (NASDAQ: NFEC) dropped 12.4 percent to $9.35.
-
Worthington Industries, Inc. (NYSE: WOR)
shares fell 10.9 percent to $32.67 after the company posted downbeat Q2 results.
-
Integrated Media Technology Limited (NASDAQ: IMTE) dropped 9.1 percent to $4.41.
-
Eyenovia, Inc. (NASDAQ: EYEN) shares
tumbled 8.7 percent to $2.83.
-
RiceBran Technologies (NASDAQ: RIBT)
dipped 7.4 percent to $3.11.
-
Washington Prime Group Inc. (NYSE: WPG)
fell 7.2 percent to $5.36 after dropping 6.18 percent on Monday. Goldman Sachs downgraded Washington Prime Group from Neutral
to Sell.
-
Comstock Resources, Inc. (NYSE: CRK)
dropped 6.6 percent to $4.68.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.